Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

AcelRx Pharmaceuticals Company Profile (NASDAQ:ACRX)

Consensus Ratings for AcelRx Pharmaceuticals (NASDAQ:ACRX) (?)
Ratings Breakdown: 2 Hold Rating(s), 7 Buy Rating(s)
Consensus Rating:Buy (Score: 2.78)
Consensus Price Target: $13.17 (105.09% upside)

Current Analysts' Coverage Summary for AcelRx Pharmaceuticals (NASDAQ:ACRX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/29/2014Cowen and CompanyReiterated RatingOutperform$15.00 -> $14.00ViewTweet This Rating  Share This Rating on StockTwits
7/29/2014Piper JaffrayDowngradeOverweight -> Neutral$14.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
7/28/2014JMP SecuritiesLower Price TargetOutperform$14.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
7/28/2014RBC CapitalLower Price TargetOutperform$15.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
7/28/2014MizuhoLower Price TargetBuy$20.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
7/28/2014Roth CapitalLower Price TargetBuy$16.00ViewTweet This Rating  Share This Rating on StockTwits
7/28/2014Canaccord GenuityDowngradeBuy -> Hold$16.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
4/10/2014Jefferies GroupInitiated CoverageBuy$17.00ViewTweet This Rating  Share This Rating on StockTwits
12/17/2013MLV & Co Boost Price TargetBuy$15.00 -> $16.50ViewTweet This Rating  Share This Rating on StockTwits
5/28/2013GuggenheimBoost Price TargetBuy$7.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2012 forward)